ADPT

Adaptive Biotechnologies Corp

SEC CIK 1478320
$17.53 +12.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$9.69M
35 open-market
Net insider flow
−$9.69M
Net selling
Filings shown
273
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at ADPT have sold a net $9.69M of stock (0 open-market buys vs 35 sells).

Largest recent trade: Robins Chad M sold $4.57M of ADPT, trimming their stake 13%.

Most active filer: Robins Chad M, with 156 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for ADPT, newest first
View on SEC EDGAR ↗
ADPT
Sell LO FRANCIS · Chief People Officer · Open-market sale · filed Mar 13, 2026 ΔOwn −9.5%

Lo Francis sold $430.7K of ADPT, trimming their stake 10%.

−$430.7K
30,593 sh @ $14
ADPT
Sell BOBULSKY SUSAN · Chief Commercial Officer, MRD · Open-market sale · filed Mar 13, 2026 ΔOwn −8.8%

Bobulsky Susan sold $544.4K of ADPT, trimming their stake 9%.

−$544.4K
41,338 sh @ $13
ADPT
Sell BENZENO SHARON · Chief Commercial Ofc Imm Med · Open-market sale · filed Mar 13, 2026 ΔOwn −19%

Benzeno Sharon sold $831.1K of ADPT, trimming their stake 19%.

−$831.1K
63,103 sh @ $13
ADPT
Sell PISKEL KYLE · Chief Financial Officer · Open-market sale · filed Mar 13, 2026 ΔOwn −6.7%

Piskel Kyle sold $245.9K of ADPT, trimming their stake 7%.

−$245.9K
18,672 sh @ $13
ADPT
Sell ROBINS HARLAN S · Chief Scientific Officer · Open-market sale · filed Mar 13, 2026 ΔOwn −7.1%

Robins Harlan S sold $1.85M of ADPT, trimming their stake 7%.

−$1.85M
140,666 sh @ $13
Advertisement
ADPT
Sell ROBINS HARLAN S · Chief Scientific Officer · Open-market sale · filed Mar 13, 2026 ΔOwn −18%

Robins Harlan S sold $4.34M of ADPT, trimming their stake 18%.

−$4.34M
329,600 sh @ $13
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 13, 2026 ΔOwn −5.1%

Robins Chad M sold $1.85M of ADPT, trimming their stake 5%.

−$1.85M
140,567 sh @ $13
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 13, 2026 ΔOwn −13%

Robins Chad M sold $4.34M of ADPT, trimming their stake 13%.

−$4.34M
329,600 sh @ $13
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 3, 2026 ΔOwn −2.6%

Robins Chad M sold $785.4K of ADPT, trimming their stake 3%.

−$785.4K
50,703 sh @ $15
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 3, 2026 ΔOwn −13%

Robins Chad M sold $4.57M of ADPT, trimming their stake 13%.

−$4.57M
289,024 sh @ $16
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 3, 2026 ΔOwn −7.4%

Robins Chad M sold $2.92M of ADPT, trimming their stake 7%.

−$2.92M
182,891 sh @ $16
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Feb 4, 2026 ΔOwn −4.8%

Robins Chad M sold $2.3M of ADPT, trimming their stake 5%.

−$2.3M
124,998 sh @ $18
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Jan 7, 2026 ΔOwn −4.6%

Robins Chad M sold $1.95M of ADPT, trimming their stake 5%.

−$1.95M
124,998 sh @ $16
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Dec 1, 2025 ΔOwn −4.4%

Robins Chad M sold $2.37M of ADPT, trimming their stake 4%.

−$2.37M
124,998 sh @ $19
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Dec 1, 2025 ΔOwn −1.2%

Robins Chad M sold $703.3K of ADPT, trimming their stake 1%.

−$703.3K
35,736 sh @ $20
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Nov 12, 2025 ΔOwn −2.9%

Robins Chad M sold $1.27M of ADPT, trimming their stake 3%.

−$1.27M
86,161 sh @ $15
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 6, 2025 ΔOwn −3.3%

Robins Chad M sold $780.9K of ADPT, trimming their stake 3%.

−$780.9K
102,218 sh @ $8
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 6, 2025 ΔOwn −2.8%

Robins Chad M sold $566.8K of ADPT, trimming their stake 3%.

−$566.8K
81,206 sh @ $7
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Mar 6, 2025 ΔOwn −1.3%

Robins Chad M sold $252.7K of ADPT, trimming their stake 1%.

−$252.7K
36,145 sh @ $7
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Feb 21, 2025 ΔOwn −3.7%

Robins Chad M sold $836.5K of ADPT, trimming their stake 4%.

−$836.5K
99,107 sh @ $8
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Feb 21, 2025 ΔOwn −6.7%

Robins Chad M sold $1.57M of ADPT, trimming their stake 7%.

−$1.57M
186,080 sh @ $8
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Feb 18, 2025 ΔOwn −7.6%

Robins Chad M sold $1.79M of ADPT, trimming their stake 8%.

−$1.79M
211,160 sh @ $9
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Feb 18, 2025 ΔOwn −5.8%

Robins Chad M sold $1.34M of ADPT, trimming their stake 6%.

−$1.34M
158,921 sh @ $8
ADPT
Sell ROBINS CHAD M · Director, CEO and Chairman · Open-market sale · filed Feb 18, 2025 ΔOwn −3.7%

Robins Chad M sold $846.4K of ADPT, trimming their stake 4%.

−$846.4K
100,287 sh @ $8
Advertisement

About ADPT insider activity

This page tracks every recent Form 4 filed for Adaptive Biotechnologies Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ADPT insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Adaptive Biotechnologies Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.